BBIO logo

BridgeBio Pharma (BBIO) Long term debt

Annual long term debt:

$1.73B-$9.63M(-0.55%)
December 31, 2024

Summary

  • As of today (May 29, 2025), BBIO annual long term debt is $1.73 billion, with the most recent change of -$9.63 million (-0.55%) on December 31, 2024.
  • During the last 3 years, BBIO annual long term debt has risen by +$4.84 million (+0.28%).
  • BBIO annual long term debt is now -0.55% below its all-time high of $1.74 billion, reached on December 31, 2023.

Performance

BBIO Long term debt Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBBIObalance sheet metrics

Quarterly long term debt:

$1.85B+$126.96M(+7.36%)
March 31, 2025

Summary

  • As of today (May 29, 2025), BBIO quarterly long term debt is $1.85 billion, with the most recent change of +$126.96 million (+7.36%) on March 31, 2025.
  • Over the past year, BBIO quarterly long term debt has increased by +$128.81 million (+7.47%).
  • BBIO quarterly long term debt is now at all-time high.

Performance

BBIO Quarterly long term debt Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBBIObalance sheet metrics

Long term debt Formula

Long-Term Debt = Bonds Payable + Long-Term Loans + Mortgage Payable + Other Long-Term Borrowings − Current Portion of Long-Term Debt

BBIO Long term debt Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-0.6%+7.5%
3 y3 years+0.3%+7.5%
5 y5 years+1780.4%+294.3%

BBIO Long term debt Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-0.6%+0.4%at high+8.5%
5 y5-year-0.6%+1780.4%at high+294.3%
alltimeall time-0.6%+3066.7%at high+3299.6%

BBIO Long term debt History

DateAnnualQuarterly
Mar 2025
-
$1.85B(+7.4%)
Dec 2024
$1.73B(-0.6%)
$1.73B(+0.1%)
Sep 2024
-
$1.73B(+0.0%)
Jun 2024
-
$1.72B(+0.0%)
Mar 2024
-
$1.72B(-0.7%)
Dec 2023
$1.74B(+0.9%)
$1.74B(+0.3%)
Sep 2023
-
$1.73B(+0.1%)
Jun 2023
-
$1.73B(+0.3%)
Mar 2023
-
$1.73B(+0.3%)
Dec 2022
$1.72B(-0.1%)
$1.72B(+0.5%)
Sep 2022
-
$1.71B(+0.2%)
Jun 2022
-
$1.71B(-0.9%)
Mar 2022
-
$1.72B(+0.1%)
DateAnnualQuarterly
Dec 2021
$1.72B(+250.9%)
$1.72B(+23.5%)
Sep 2021
-
$1.39B(+0.1%)
Jun 2021
-
$1.39B(+1.2%)
Mar 2021
-
$1.38B(+180.3%)
Dec 2020
$490.53M(+434.4%)
$490.53M(+2.2%)
Sep 2020
-
$480.13M(+0.9%)
Jun 2020
-
$475.68M(+1.2%)
Mar 2020
-
$470.02M(+412.1%)
Dec 2019
$91.79M(+68.4%)
$91.79M(+22.4%)
Sep 2019
-
$75.02M(+0.0%)
Jun 2019
-
$75.00M(+36.7%)
Mar 2019
-
$54.86M(+0.6%)
Dec 2018
$54.51M
$54.51M

FAQ

  • What is BridgeBio Pharma annual long term debt?
  • What is the all time high annual long term debt for BridgeBio Pharma?
  • What is BridgeBio Pharma annual long term debt year-on-year change?
  • What is BridgeBio Pharma quarterly long term debt?
  • What is the all time high quarterly long term debt for BridgeBio Pharma?
  • What is BridgeBio Pharma quarterly long term debt year-on-year change?

What is BridgeBio Pharma annual long term debt?

The current annual long term debt of BBIO is $1.73B

What is the all time high annual long term debt for BridgeBio Pharma?

BridgeBio Pharma all-time high annual long term debt is $1.74B

What is BridgeBio Pharma annual long term debt year-on-year change?

Over the past year, BBIO annual long term debt has changed by -$9.63M (-0.55%)

What is BridgeBio Pharma quarterly long term debt?

The current quarterly long term debt of BBIO is $1.85B

What is the all time high quarterly long term debt for BridgeBio Pharma?

BridgeBio Pharma all-time high quarterly long term debt is $1.85B

What is BridgeBio Pharma quarterly long term debt year-on-year change?

Over the past year, BBIO quarterly long term debt has changed by +$128.81M (+7.47%)
On this page